Basecamp Research
- Health & Biotech
- London, GB
- Private
- basecamp-research.com
London AI drug-discovery company that trains models on large biological datasets to design therapeutics, including cell therapies.
$140MEquity raised in 2025–20262025 — · 2026 $140M · 1 equity round
$140MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 1 source
Earlier rounds not yet sourced. Basecamp Research raised before 23 Sep 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series CAmount$140MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 15
- S321
- Catalio Capital Management
- European Tech Collective
- Firebrand River Capital
- Inception Fund
- King Philanthropies
- Menlo Ventures Anthology Fund
- NATO Innovation Fund
- Nvidia
- PostScriptum
- Redalpine
- Singular VC
- The Rockefeller Foundation
- True Ventures
- UK Sovereign AI Fund
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
humans&AI Labs · $480M in 2025–2026Shared: S32, NvidiaEnvedaHealth · $461M in 2025–2026Shared: Catalio Capital Management, True VenturesSnorkel AIAI Infra · $450M in 2025–2026Shared: S32AnthropicAI Labs · $113B in 2025–2026Shared: NvidiaSafe SuperintelligenceAI Labs · $7B in 2025–2026Shared: NvidiaIneffable IntelligenceAI Labs · $1.1B in 2025–2026Shared: Nvidia, UK Sovereign AI Fund
Also in the London hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Basecamp Research and its logo are trademarks of their owners, used here for identification only.
